Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Methamphetamine Dependence
NCT00687713Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- May 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupropion in methamphetamine use disorder (MUD), sponsored by National Institute on Drug Abuse. Primary endpoint: Number of Subjects Showing Abstinence at 12 weeks. Started May 2008; status: completed.
02
Drugs
bupropion
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00687713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00687713.